Hrt Financial LP Lexicon Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

$15.6 Billion
Q1 2024

A detailed history of Hrt Financial LP transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 16,965 shares of LXRX stock, worth $28,161. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,965

Holding current value

$28,161

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.3 - $3.58 $22,054 - $60,734	16,965 New	16,965 $40,000
Q2 2023 Aug 11, 2023	BUY	$2.15 - $3.49 $427,153 - $693,379	198,676 New	198,676 $454,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $88,403 - $156,301	45,569 New	45,569 $109,000
Q2 2022 Aug 12, 2022	SELL	$1.31 - $2.69 $317,296 - $651,547	-242,211 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.95 - $3.89 $274,267 - $547,128	140,650 Added 138.49%	242,211 $506,000

Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $386,947 - $625,615	101,561 New	101,561 $400,000
Q3 2020 Nov 13, 2020	SELL	$1.44 - $2.1 $45,449 - $66,280	-31,562 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.75 - $2.3 $55,233 - $72,592	31,562 New	31,562 $62,000
Q4 2019 Feb 14, 2020	SELL	$3.16 - $5.15 $51,710 - $84,274	-16,364 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.2 - $6.66 $19,636 - $108,984	16,364 New	16,364 $49,000

Others Institutions Holding LXRX

# of Institutions

122

Shares Held

159M

Call Options Held

2.11M

Put Options Held

412K

Artal Group S.A. Luxembourg, N4

118M
Shares

$195 Million
15.21% of portfolio
Black Rock Inc. New York, NY

7.69M
Shares

$12.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.4M
Shares

$10.6 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.54M
Shares

$5.88 Million
0.19% of portfolio
Geode Capital Management, LLC Boston, MA

2.39M
Shares

$3.97 Million
0.0% of portfolio

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $313M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account